Statins might reduce melanoma recurrence
Australian study shows the greatest protective effect is in men and patients with ulcerated primary melanoma
Long-term statin users have a significantly reduced risk of melanoma recurrence compared with those who are not prescribed the medication, a study suggests.
A research team, led by the QIMR Berghofer Medical Research Institute in Brisbane, followed 700 Queensland-based patients, who were newly diagnosed with localised tumour-stage T1b-T4 primary cutaneous melanoma and at high risk of spread from 2010 to 14.
